Millipore Sigma Vibrant Logo

300270 PARP Inhibitor III, DPQ - CAS 129075-73-6 - Calbiochem

Overview

Replacement Information

Key Spec Table

CAS #Empirical Formula
129075-73-6C₁₈H₂₆N₂O₂

Pricing & Availability

Catalogue Number AvailabilityPackaging Qty/Pack Price Quantity
300270-1MG
Retrieving availability...
Limited Availability
Limited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      Plastic ampoule 1 mg
      Retrieving price...
      Price could not be retrieved
      Minimum Quantity is a multiple of
      Maximum Quantity is
      Upon Order Completion More Information
      You Saved ()
       
      Request Pricing
      Description
      OverviewA potent and selective inhibitor of poly(ADP-ribose) polymerase (PARP; IC50 = 40 nM). Significantly reduces infarcet volume in rat focual cerebrale ischemia model.
      Catalogue Number300270
      Brand Family Calbiochem®
      Synonyms3,4-Dihydro-5[4-(1-piperindinyl)butoxy]-1(2H)-isoquinoline
      References
      ReferencesEliasson, M.J., et al. 1997. Nat. Med. 3, 1089.
      Takahashi, K., et al. 1997. J. Cereb. Blood Flow Metabl. 17, 1137.
      Suto, M.J., et al. 1991. Anticancer Drug Des. 6, 107.
      Product Information
      CAS number129075-73-6
      ATP CompetitiveN
      FormOff-white solid
      Hill FormulaC₁₈H₂₆N₂O₂
      Chemical formulaC₁₈H₂₆N₂O₂
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetPARP
      Primary Target IC<sub>50</sub>40 nM
      Purity≥90% by HPLC
      Physicochemical Information
      Cell permeableN
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      R PhraseR: 20/21/22

      Harmful by inhalation, in contact with skin and if swallowed.
      S PhraseS: 36

      Wear suitable protective clothing.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Harmful
      Storage -20°C
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze at -20°C. Stock solutions are stable for up to 1 month at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      300270-1MG 04055977198010

      Documentation

      PARP Inhibitor III, DPQ - CAS 129075-73-6 - Calbiochem SDS

      Title

      Safety Data Sheet (SDS) 

      PARP Inhibitor III, DPQ - CAS 129075-73-6 - Calbiochem Certificates of Analysis

      TitleLot Number
      300270

      References

      Reference overview
      Eliasson, M.J., et al. 1997. Nat. Med. 3, 1089.
      Takahashi, K., et al. 1997. J. Cereb. Blood Flow Metabl. 17, 1137.
      Suto, M.J., et al. 1991. Anticancer Drug Des. 6, 107.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision17-June-2008 RFH
      Synonyms3,4-Dihydro-5[4-(1-piperindinyl)butoxy]-1(2H)-isoquinoline
      DescriptionA very potent and selective poly(ADP-ribose)polymerase (PARP) inhibitor (IC50 = 40 nM). Significantly reduces infarcet volume in rat focual cerebrale ischemia model.
      FormOff-white solid
      CAS number129075-73-6
      Chemical formulaC₁₈H₂₆N₂O₂
      Structure formulaStructure formula
      Purity≥90% by HPLC
      SolubilityDMSO (5 mg/ml)
      Storage -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze at -20°C. Stock solutions are stable for up to 1 month at -20°C.
      Toxicity Harmful
      ReferencesEliasson, M.J., et al. 1997. Nat. Med. 3, 1089.
      Takahashi, K., et al. 1997. J. Cereb. Blood Flow Metabl. 17, 1137.
      Suto, M.J., et al. 1991. Anticancer Drug Des. 6, 107.